Randomized trial · people
MK-677: fat-free mass rose 1.1 kg vs -0.5 kg on placebo at 1 year
Checked against the paper Randomized trialPublished by PepVault
The takeaway
In healthy older adults, a year of daily MK-677 added fat-free mass and body weight but did not change strength or function, and it came with higher fasting glucose and lower insulin sensitivity.
- Kind
- Randomized trial
- Studied in
- People
- Number studied
- 65
- Published
- 2008
- Journal
- Ann Intern Med
What they tested
The team tested whether daily oral MK-677 could raise growth hormone to young-adult levels, prevent the loss of fat-free mass and cut belly fat around the organs in healthy older adults, without serious side effects.
How the study was done
A 2-year, double-blind (neither participants nor staff knew who got what), randomized, placebo-controlled trial with a modified crossover design in 65 healthy adults aged 60 to 81, who took 25 mg of MK-677 or a dummy pill by mouth once a day. Fat-free mass (everything in the body that isn't fat) and abdominal visceral fat were the main outcomes at 1 year.

Model. Individual results vary.
What they found
Growth hormone and insulin-like growth factor I (IGF-I) levels rose into the range of healthy young adults, with no serious side effects. Fat-free mass changed by 1.1 kg in the MK-677 group and -0.5 kg in the placebo group (P < 0.001), and body weight rose 2.7 kg versus 0.8 kg (P = 0.003); belly fat around the organs and total fat mass did not differ between groups, but limb fat rose more on MK-677 (1.1 kg vs. 0.24 kg). In the MK-677 group, fasting blood glucose went up by an average of 0.3 mmol/L (5 mg/dL), insulin sensitivity fell, and cortisol rose 47 nmol/L, while LDL cholesterol dropped 0.14 mmol/L from baseline. The most common side effects were a rise in appetite that faded within a few months and short-lived, mild swelling of the lower legs and muscle pain, and the gain in fat-free mass did not translate into changes in strength or function.
What it doesn’t show
The trial was too small and too short to judge effects on strength and day-to-day function, and it included only healthy older adults. The 2-year results were exploratory analyses.
The paper
Nass et al. Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial. Ann Intern Med. 2008.
The compound
More studies on MK-677
- MK-677 raised IGF-1 but not most function after hip fractureRandomized trial · people · 2011
- MK-677 reversed diet-driven nitrogen loss in 8 healthy adultsRandomized trial · people · 1998
- MK-677: about 50% more stage IV sleep in young adults on 25 mgClinical trial · people · 1997
- Every study on MK-677
Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.